Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 2
1971 4
1972 1
1973 5
1974 3
1975 4
1976 5
1977 3
1978 3
1979 2
1980 3
1981 2
1982 3
1983 2
1984 6
1985 8
1986 10
1987 9
1988 10
1989 8
1990 6
1991 12
1992 7
1993 10
1994 14
1995 7
1996 17
1997 12
1998 9
1999 10
2000 10
2001 14
2002 8
2003 7
2004 11
2005 10
2006 7
2007 5
2008 13
2009 6
2010 12
2011 9
2012 5
2013 6
2014 12
2015 5
2016 8
2017 6
2018 9
2019 2
2020 4
2021 5
2022 5
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

369 results

Results by year

Filters applied: . Clear all
Page 1
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.
Sartore-Bianchi A, Trusolino L, Martino C, Bencardino K, Lonardi S, Bergamo F, Zagonel V, Leone F, Depetris I, Martinelli E, Troiani T, Ciardiello F, Racca P, Bertotti A, Siravegna G, Torri V, Amatu A, Ghezzi S, Marrapese G, Palmeri L, Valtorta E, Cassingena A, Lauricella C, Vanzulli A, Regge D, Veronese S, Comoglio PM, Bardelli A, Marsoni S, Siena S. Sartore-Bianchi A, et al. Among authors: comoglio pm. Lancet Oncol. 2016 Jun;17(6):738-746. doi: 10.1016/S1470-2045(16)00150-9. Epub 2016 Apr 20. Lancet Oncol. 2016. PMID: 27108243 Free article. Clinical Trial.
MET∆14 promotes a ligand-dependent, AKT-driven invasive growth.
Cerqua M, Botti O, Arigoni M, Gioelli N, Serini G, Calogero R, Boccaccio C, Comoglio PM, Altintas DM. Cerqua M, et al. Among authors: comoglio pm. Life Sci Alliance. 2022 May 30;5(10):e202201409. doi: 10.26508/lsa.202201409. Print 2022 Oct. Life Sci Alliance. 2022. PMID: 35636967 Free PMC article.
Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation.
Orzan F, De Bacco F, Lazzarini E, Crisafulli G, Gasparini A, Dipasquale A, Barault L, Macagno M, Persico P, Pessina F, Bono B, Giordano L, Zeppa P, Melcarne A, Cassoni P, Garbossa D, Santoro A, Comoglio PM, Indraccolo S, Simonelli M, Boccaccio C. Orzan F, et al. Among authors: comoglio pm. Clin Cancer Res. 2023 Apr 3;29(7):1252-1266. doi: 10.1158/1078-0432.CCR-22-2903. Clin Cancer Res. 2023. PMID: 36648487 Free PMC article.
Invasive growth: from development to metastasis.
Comoglio PM, Trusolino L. Comoglio PM, et al. J Clin Invest. 2002 Apr;109(7):857-62. doi: 10.1172/JCI15392. J Clin Invest. 2002. PMID: 11927611 Free PMC article. Review. No abstract available.
The c-met/HGF receptor in human tumours.
Giordano S, di Renzo MF, Olivero M, Mondino A, Zhen Z, Medico E, Comoglio PM. Giordano S, et al. Among authors: comoglio pm. Eur J Cancer Prev. 1992 Oct;1 Suppl 3:45-9. doi: 10.1097/00008469-199210003-00007. Eur J Cancer Prev. 1992. PMID: 1467788 Review. No abstract available.
Invasive growth: a genetic program.
Gentile A, Comoglio PM. Gentile A, et al. Among authors: comoglio pm. Int J Dev Biol. 2004;48(5-6):451-6. doi: 10.1387/ijdb.041799ag. Int J Dev Biol. 2004. PMID: 15349819 Free article. Review.
Cancer therapy: can the challenge be MET?
Corso S, Comoglio PM, Giordano S. Corso S, et al. Among authors: comoglio pm. Trends Mol Med. 2005 Jun;11(6):284-92. doi: 10.1016/j.molmed.2005.04.005. Trends Mol Med. 2005. PMID: 15949770 Review.
369 results